Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
27,41 USD | +3,87 % | +2,97 % | -2,42 % |
Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Biopharmaceutical Royalties
100,0
%
| 2 237 | 100,0 % | 2 355 | 100,0 % | +5,24 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 237 | 100,0 % | 2 355 | 100,0 % | +5,24 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 01/01/96 |
Terrance Coyne
DFI | Director of Finance/CFO | 42 | 01/01/10 |
Arthur McGivern
CIO | Chief Investment Officer | - | 12/10/22 |
Marshall Urist
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/01/13 |
Eric Schneider
CTO | Chief Tech/Sci/R&D Officer | - | 21/09/23 |
James Reddoch
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/07/08 |
Brienne Kugler
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/14 |
Sara Klymkowsky
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/12 |
George Lloyd
CIO | Chief Investment Officer | 64 | 01/01/11 |
George Grofik
IRC | Investor Relations Contact | - | 01/01/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Rory Riggs
FOU | Founder | 71 | 01/01/96 |
Errol de Souza
BRD | Director/Board Member | 70 | 01/06/20 |
David Hodgson
BRD | Director/Board Member | 67 | 23/06/22 |
Ted Love
BRD | Director/Board Member | 65 | 30/07/20 |
Henry Fernandez
BRD | Director/Board Member | 65 | 30/07/20 |
Gregory Norden
BRD | Director/Board Member | 66 | 11/02/20 |
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 01/01/96 |
Mario Giuliani
BRD | Director/Board Member | 52 | 01/06/20 |
Bonnie Bassler
BRD | Director/Board Member | 61 | 16/06/20 |
57 | - |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 50 000 | 0 | 0 | 85,52 % |
Action B | 1 | 146 456 241 | 0 | 0 | |
Action C | 1 | 450 981 030 | 385 668 432 ( 85,52 %) | 0 |
Coordonnées société
Royalty Pharma Plc
110 East 59th Street 33rd floor
10022, New York
+212 883 0200
http://www.royaltypharma.comSociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Royalty Pharma Holdings Ltd.
Royalty Pharma Holdings Ltd. Financial ConglomeratesFinance Royalty Pharma Holdings Ltd. operates as an investment holding company. The company was founded on February 10, 2020 and is headquartered in Bristol, the United Kingdom. |
Financial Conglomerates
|
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-2,42 % | 12,36 Md | |
+40,73 % | 739 Md | |
+32,83 % | 598 Md | |
-6,30 % | 353 Md | |
+15,15 % | 318 Md | |
+4,05 % | 285 Md | |
+15,00 % | 240 Md | |
-5,52 % | 206 Md | |
+6,17 % | 164 Md | |
-0,45 % | 162 Md |
- Bourse
- Actions
- Action RPRX
- Société Royalty Pharma plc